From: Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
Vaccine protection duration
Cohort ages
2.5 years
1, 3, 5, 7, 9, 11, 13
5 years
1, 6, 11
10 years
1, 11
20 years
1